|
AVIR Atea Pharmaceuticals Inc 1593899 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-32,933,000.00 |
| Balance Sheet |
|
Current Assets
|
$228,665,000.00 |
|
Assets
|
$232,282,000.00 |
|
Current Liabilities
|
$28,124,000.00 |
|
Liabilities
|
$39,784,000.00 |
|
Equity
|
$204,158,000.00 |
|
Shares Out
|
80204699.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-83,475,000.00 |
|
Investing Cash Flow
|
$64,053,000.00 |
| Market Analysis |
Market Cap
|
$429,897,186.64 |
|
Price
|
$5.36 |
|
BVPS
|
2.55 |
|
PB
|
2.10 |
|
EPS
|
-0.41 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.57 |
|
|
2026-05-12 |
-0.57 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.44 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.53 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AVIR documents filed with the SEC.
AVIR Filings
Clear
